On Invalid Date, 60 Degrees Pharmaceuticals (NASDAQ: SXTP) reported Q4 2023 earnings per share (EPS) of -$0.44, up 36.23% year over year. Total 60 Degrees Pharmaceuticals earnings for the quarter were -$2.08 million. In the same quarter last year, 60 Degrees Pharmaceuticals's earnings per share (EPS) was -$0.69.
As of Q2 2024, 60 Degrees Pharmaceuticals's earnings has grown year over year. 60 Degrees Pharmaceuticals's earnings in the past year totalled -$3.92 million.
What was SXTP's revenue last quarter?
On Invalid Date, 60 Degrees Pharmaceuticals (NASDAQ: SXTP) reported Q4 2023 revenue of $371.00 thousand up 42.31% year over year. In the same quarter last year, 60 Degrees Pharmaceuticals's revenue was $260.69 thousand.
What was SXTP's revenue growth in the past year?
As of Q2 2024, 60 Degrees Pharmaceuticals's revenue has grown -50.4% year over year. This is 195.03 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. 60 Degrees Pharmaceuticals's revenue in the past year totalled $253.57 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.